Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.

Latest action: Combined with S4194 (SCS)

Voted 6/11/2026View source

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

6/11/2026Combined with S4194 (SCS)
5/11/2026Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee